SCHEMBL6046334

SCHEMBL6046334

N=C(N)c1ncc2[nH]cnc2n1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.55
▸ KDM4E B2RXH2 1/20 0.50
▸ RXFP1 Q9HBX9 1/20 0.47
▸ CDK2 P24941 2/20 0.41
▸ PAK1 Q13153 1/20 0.39
▸ CCNT1 O60563 1/20 0.38
▸ CDK1 P06493 1/20 0.38
▸ CCNB1 P14635 1/20 0.38
▸ CDK7 P50613 1/20 0.38
▸ CDK9 P50750 1/20 0.38
▸ CCNH P51946 1/20 0.38
▸ POLA1 P09884 1/20 0.33
▸ MAP3K7 O43318 1/20 0.31
▸ MAP3K6 O95382 1/20 0.31
▸ MAP3K5 Q99683 1/20 0.31
▸ PDPK1 O15530 1/20 0.31
▸ GDA Q9Y2T3 1/20 0.31
▸ LMNA P02545 1/20 0.30
▸ PARP1 P09874 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1721311 0.82 ALDH1A1 (0.55) ALDH1A1KDM4ERXFP1CDK2PAK1
SCHEMBL788098 0.76 ALDH1A1 (0.52) ALDH1A1KDM4ERXFP1CDK2PAK1
SCHEMBL30075070 0.76 ALDH1A1 (0.52) ALDH1A1KDM4ERXFP1CDK2PAK1
SCHEMBL30556758 0.75 ALDH1A1 (0.50) ALDH1A1KDM4ERXFP1CDK2PAK1
SCHEMBL29599053 0.75 RXFP1 (0.51) ALDH1A1KDM4ERXFP1CDK2PAK1
SCHEMBL7771676 0.75 ALDH1A1 (0.50) ALDH1A1KDM4ERXFP1CDK2PAK1
SCHEMBL28190667 0.72 ALDH1A1 (0.47) ALDH1A1KDM4ERXFP1CDK2PAK1
SCHEMBL6046332 0.71 KDM4E (0.31) ALDH1A1KDM4E
SCHEMBL28486689 0.71 ALDH1A1 (0.46) ALDH1A1KDM4ERXFP1CDK2PAK1
SCHEMBL29400266 0.71 KDM4E (0.46) ALDH1A1KDM4ERXFP1CDK2PAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4161519-A1 PURINES AND METHODS OF THEIR USE Yumanity Therapeutics, Inc. (US) 2023-04-12 — — EP disclosed
EP-2953470-A1 2,6,7 SUBSTITUTED PURINES AS HDM2 INHIBITORS Merck Sharp & Dohme Corp. (US) 2015-12-16 — — EP disclosed
WO-2014123882-A1 2,6,7 SUBSTITUTED PURINES AS HDM2 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2014-08-14 — — WO disclosed
US-20060199198-A1 Polymorphic DNA fragments and uses thereof SOLEXA, INC., 2006-09-07 — — US disclosed
Send feedback